Physician
Neurology
Dr. Anne H. Cross, MD
|
|
Give Review
Anne Cross is an expert in the field of Neurology. She graduated from University of Alabama School of Medicine. University of Alabama School of Medicine is ranked 37/17 in Research/PrimaryCare. She received awards:"CMS Meaningful Use Stage 1 Certification", "Faculty Achievement Award", "President's Achievement Award", ""Hall of Fame" for Researchers", "Best Doctors in America", ""Best Doctors in America", Central Region", "Harry Weaver Neuroscience Scholar", "Fellow", "Award for Academic Excellence", "Superior Scholastic Achievement Certificate", "National Merit Scholarship Recipient" and "Presidential Scholar". Anne H. Cross is also a published physician. She has 139 publication published. The most recent publication is: Peroxynitrite formation within the central nervous system in active multiple sclerosis. She accepts Medicare.
Publications
- On the Relationship between Cellular and Hemodynamic Properties of the Human Brain Cortex throughout Adult Lifespan.
- Simultaneous multiangular relaxometry of tissue with MRI (SMART MRI): Theoretical Background and proof of concept.
- Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.
- TREM2 regulates microglial cell activation in response to demyelination in vivo.
- Differentiation and quantification of inflammation, demyelination and axon injury or loss in Multiple sclerosis.
- Antisense therapy: Potential tool to reduce activity in MS via protein expression inhibition.
- Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema.
- Active and progressive: A new duality of MS classification.
- Axonal transport rate decreased at the onset of Optic neuritis in EAE mice.
- Apolipoprotein E mediation of neuro-inflammation in a murine model of Multiple sclerosis.
- Diffusion fMRI detects white-matter dysfunction in mice with acute Optic neuritis.
- Established and novel Disease-modifying treatments in multiple sclerosis.
- On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI.
- MS and related Disorders: groundbreaking news.
- Decreased circulating miRNA levels in patients with primary progressive Multiple sclerosis.
- Monoclonal antibodies as Disease modifying therapy in multiple sclerosis.
- Genetic risk variants in African Americans with Multiple sclerosis.
- Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within Multiple sclerosis lesions.
- Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating Disease.
- Lack of adiponectin leads to increased lymphocyte activation and increased Disease severity in a mouse model of multiple sclerosis.
- Interferon beta use and disability prevention in relapsing-remitting Multiple sclerosis.
- Improved in vivo diffusion tensor imaging of human cervical spinal cord.
- CXCL13 is a biomarker of inflammation in Multiple sclerosis, neuromyelitis optica, and other neurological conditions.
- Diffusion Tensor Imaging in Acute Optic Neuropathies: Predictor of Clinical Outcomes.
- Lack of response to monoclonal antibody therapy in neuromyelitis Optica.
- Radial diffusivity predicts demyelination in ex vivo Multiple sclerosis spinal cords.
- Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.
- Spinal cord ring enhancement in Multiple sclerosis.
- ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling.
- Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in Multiple sclerosis.
- The four seasons of Multiple sclerosis.
- In vivo quantitative evaluation of brain tissue damage in Multiple sclerosis using gradient echo plural contrast imaging technique.
- Rostrocaudal analysis of corpus callosum demyelination and axon damage across Disease stages refines diffusion tensor imaging correlations with pathological features.
- Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in Multiple sclerosis.
- The present efficacy of Multiple sclerosis therapeutics: Is the new 66% just the old 33%?
- Acute and bilateral blindness due to optic Neuropathy associated with copper deficiency.
- Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis.
- Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyNeuropathy.
- Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis.
- Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proInflammatory cytokines.
- Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging.
- Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of Multiple sclerosis.
- Selective vulnerability of Cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging.
- Higher IgG index found in African Americans versus Caucasians with Multiple sclerosis.
- B cells: no longer the nondominant arm of Multiple sclerosis.
- Toward accurate diagnosis of white matter pathology using diffusion tensor imaging.
- A little stress is good: IFN-gamma, demyelination, and Multiple sclerosis.
- Elevated CSF free kappa light chains correlate with disability prognosis in Multiple sclerosis.
- Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving Optic nerve injury in mice with retinal ischemia.
- Detecting axon damage in spinal cord from a mouse model of Multiple sclerosis.
- Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum.
- Multiple sclerosis and black holes: connecting the pixels.
- Demyelination increases radial diffusivity in corpus callosum of mouse brain.
- Humoral immunity in Multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
- Does the hepatitis B vaccine cause Multiple sclerosis?
- The relationship of sleep disturbances and fatigue in Multiple sclerosis.
- Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse Optic nerve after retinal ischemia.
- Neurologic manifestations of celiac Disease: proven, or just a gut feeling?
- Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water.
- Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
- The participation of the hemes of flavocytochrome b245 in the electron transfer process in NADPH oxidase.
- An epitope within the DNA-binding domain of the herpes simplex virus immediate early protein Vmw175 is conserved in the varicella-zoster virus gene 62 protein.
- Effect of fasting, hypocaloric feeding, and refeeding on the energetics of stimulated rat muscle as assessed by nuclear magnetic resonance spectroscopy.
- The catalytic subunit of the DNA polymerase of herpes simplex virus type 1 interacts specifically with the C terminus of the UL8 component of the viral helicase-primas...
- Provocative pattern of rearrangements of the genes for the gamma and beta chains of the T-cell receptor in human leukemias.
- Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1.
- Design and implementation of the stavudine parallel-track program.
- A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.
- Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study.
- Autoimmune demyelination in transgenic E alpha d-positive A.CA mice. Comparison with E-negative A.CA mice.
- Association of Chlamydia pneumoniae and Multiple sclerosis: stage two?
- Caveat regarding immunoglobulin therapy in Multiple sclerosis.
- The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli.
- Fampridine-SR in Multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study.
- Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.
- MS: the return of the B cell.
- Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination.
- Antigen processing of myelin basic protein is required prior to recognition by T cells inducing EAE.
- Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of Multiple sclerosis.
- Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system.
- Phosphatidylserine, a putative inhibitor of tumor necrosis factor, prevents autoimmune demyelination.
- Relapsing autoimmune demyelination: a role for vascular addressins.
- Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler''s virus infection.
- T cell autoimmunity in the central nervous system--a new twist at an old rope.
- Landmark papers in Multiple sclerosis.
- Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency.
- Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental al...
- Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
- Multiple encephalitogenic peptides of myelin basic protein in A.CA mice.
- Adhesion-related molecules in the central nervous system. Upregulation correlates with Inflammatory cell influx during relapsing experimental autoimmune encephalomyeli...
- Postpartum Cerebral vasospasm treated with hypervolemic therapy.
- Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
- Adoptively transferred acute and chronic relapsing autoimmune encephalomyelitis in the PL/J mouse and observations on altered pathology by intercurrent virus infection.
- Axonal dystrophy as a consequence of long-term demyelination.
- Adoptive transfer of experimental allergic encephalomyelitis and localization of the encephalitogenic epitope in the SWR mouse.
- Fatigue therapy in Multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
- Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelin...
- Antibodies to beta-interferons in Multiple sclerosis: can we neutralize the controversy?
- Serial adoptive transfer of murine experimental allergic encephalomyelitis: successful transfer is dependent on active Disease in the donor.
- Quantification of increased cellularity during Inflammatory demyelination.
- Genetic risk and a primary role for cell-mediated immune mechanisms in Multiple sclerosis.
- Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.
- Multiple sclerosis: oligoclonal bands still yield clues about Multiple sclerosis.
- Dysmyelinated axons in shiverer mice are highly vulnerable to alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor-mediated Toxicity.
- Cerebrospinal fluid progranulin levels in patients with different Multiple sclerosis subtypes.
- Genetic variation in the IL7RA/IL7 pathway increases Multiple sclerosis susceptibility.
- MS and the B cell controversy.
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new Multiple sclerosis susceptibility loci.
- Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
- Candidate gene analysis of selectin cluster in patients with Multiple sclerosis.
- Assessing Optic nerve pathology with diffusion MRI: from mouse to human.
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with Multiple sclerosis and CNS inflammation.
- B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice.
- Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of Multiple sclerosis.
- Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.
- Rituximab reduces B cells and T cells in cerebrospinal fluid of Multiple sclerosis patients.
- NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis.
- Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of ex...
- Interferon-gamma produced by encephalitogenic cells induces suppressors of cytokine signaling in primary murine astrocytes.
- Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in Multiple sclerosis.
- Identification of the encephalitogenic epitopes of CNS proteolipid protein in BALB/c mice.
- Rapid onset mitoxantrone-induced cardioToxicity in secondary progressive multiple sclerosis.
- Disability in Optic neuritis correlates with diffusion tensor-derived directional diffusivities.
- Increased diffusivity in acute Multiple sclerosis lesions predicts risk of black hole.
- Radial diffusivity in remote optic neuritis Discriminates visual outcomes.
- Rituximab add-on therapy for breakthrough relapsing Multiple sclerosis: a 52-week phase II trial.
- Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.
- Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
- Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2.
- Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).
- T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
- B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide.
- Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating Disease.
- HPRT mutant T-cell lines from Multiple sclerosis patients recognize myelin proteolipid protein peptides.
- Peroxynitrite formation within the central nervous system in active Multiple sclerosis.
- Optical coherence tomography is less sensitive than visual evoked potentials in Optic neuritis.
- Optical coherence tomography differs in neuromyelitis optica compared with Multiple sclerosis.
- Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system.
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Cerebral Artery Thrombosis
- Convulsions
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Faculty Achievement Award
- President's Achievement Award
- "Hall of Fame" for Researchers
- Best Doctors in America
- "Best Doctors in America", Central Region
- Harry Weaver Neuroscience Scholar
- Fellow
- Award for Academic Excellence
- Superior Scholastic Achievement Certificate
- National Merit Scholarship Recipient
- Presidential Scholar
Education
-
Albert Einstein - Montefiore Medical Center -
National Institutes of Health Clinical Center -
George Washington University -
Scripps Mercy Hospital -
University of Alabama School of Medicine
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1073531596 | |
| NPPES Provider LastName | CROSS | |
| NPPES Provider FirstName | ANNE | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Neurology | |
| Total Claim Count | 834.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073531596 |
| Last Name Of The Provider | CROSS |
| First Name Of The Provider | ANNE |
| View All |
Similar Doctors
|
|
Dr. Christopher D. Smyser, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynn Zhang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Noetzel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bingzhong Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yi Pan, MD |
|
|
Dr. Kelvin A. Yamada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Curfman, MD |
|
|
Dr. Joshua H. Buck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kyle T. Mitchell, MD |